Hosted on MSN1mon
Innovent Biologics’ Limertinib Gains Approval for Advanced Lung Cancer Treatment
Discover outperforming stocks and invest smarter with Top Smart Score Stocks Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener Innovent ...
Yahoo Finance4d
China's First IGF-1R Monoclonal Antibody: Innovent Announces NMPA approval of SYCUME® for the Treatment of Thyroid Eye Disease
SAN FRANCISCO and SUZHOU, China, March 14, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that ...
pharmaphorum3d
Innovent throws its hat further into China's GLP-1 ring
Innovent Biologics is planning a second filing for its dual GLP-1/glucagon agonist mazdutide in China, as it tries to carve out a share of a market currently dominated by Novo Nordisk and Eli Lilly.
Pharmabiz27d
Innovent receives second fast track designation from US FDA for IBI363 in squamous non-small cell lung cancer
Innovent Biologics, Inc. (Innovent), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, ...
Business Insider11d
Analysts Have Conflicting Sentiments on These Healthcare Companies: Vaxcyte (PCVX), Envista Holdings (NVST) and Innovent Biologics (OtherIVBXF)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Vaxcyte (PCVX – Research Report), Envista Holdings (NVST – Research Report) and Innovent ...